Venturing Beyond The Magic Kingdom: Former Disney CFO And Fortune 500 Veteran Takes The Reins At Lucy Scientific
Venturing Beyond The Magic Kingdom: Former Disney CFO And Fortune 500 Veteran Takes The Reins At Lucy Scientific
As of July 13, Lucy Scientific Discovery (NASDAQ:LSDI) has a new principal. Current executive chairman, Richard Nanula, will retain this role while succeeding Chris McElvany as the company's CEO toward bringing "significant strategic focus and leadership" to Lucy.
截至7月13日 露西科學發現 納斯達克股票代碼：LSDI）有了新的校長。當前 執行董事長，理查德·納努拉，將保留此角色，同時 接替克里斯·麥克爾瓦尼 作爲公司的首席執行官，努力爲露西帶來 “重要的戰略重點和領導力”。
Nanula previously served as CFO in Fortune 500 companies such as The Walt Disney Corporation (NYSE:DIS) and sector-related biotech firm Amgen Inc. (NASDAQ: AMGN), and holds decades of senior leadership experience including the oversight of over $50 billion in M&A and financing transactions.
Nanula 之前曾擔任 《財富》500強公司的首席財務官 比如 沃爾特·迪斯尼公司 （紐約證券交易所代碼：DIS）和與行業相關的生物技術公司 安進公司 （納斯達克股票代碼：AMGN），擁有數十年的高級領導經驗，包括對超額的監督 500億美元的併購和融資 交易。
It is intended that Lucy's founder and former CEO McElvany will remain "closely involved" with the company as a consultant, leveraging his knowledge and industry expertise to support the transition.
露西的創始人兼前首席執行官麥克爾瓦尼打算以顧問的身份保持 “密切參與” 公司，利用他的知識和行業專業知識來支持過渡。
Lucy owns holdings and operations in a variety of what it calls "psychotropic" businesses. Through its Canadian Controlled Drugs and Substances Dealer's license and together with wholly-owned subsidiary LSDI Manufacturing Inc.'s specialized license, the parent company can develop, sell, deliver and manufacture pharmaceutical-grade Active Pharmaceutical Ingredients (APIs) used in controlled substances and their raw material precursors.
露西擁有各種所謂的 “精神藥物” 業務的股份和業務。通過其加拿大管制藥物和物質經銷商的執照，再加上全資持有 子公司 LSDI 製造公司根據專業許可證，母公司可以開發、銷售、交付和製造用於受控物質及其原材料前體的醫藥級活性藥物成分（API）。
Additionally, Lucy is set to advance the understanding and applications of psychoactive medicines for improved mental health outcomes and well-being enhancement.
此外，露西還將增進對精神活性藥物的理解和應用，以改善心理健康狀況和增強幸福感。
McElvany says Nanula's "remarkable history of leadership" at major corporations makes him the ideal candidate for Lucy's next phase of growth.
McElvany 納努拉說，納努拉在大公司的 “非凡領導歷史” 使他成爲露西下一階段增長的理想人選。
See Also: Lucy Scientific Acquires Psilocybin And CBD Therapy Asset From Wesana Health
另見：露西科學從 Wesana Health 手中收購了 psilocybin 和 CBD 療法資產
"I am extremely excited as both founder and a significant shareholder to work with Richard and the Lucy team to innovate and create value for shareholders going forward," he concluded.
他總結說：“作爲創始人和重要股東，我很高興能與Richard和Lucy團隊合作，爲未來的股東進行創新和創造價值。”
Nanula echoed the sentiment, adding that he views Lucy in "a unique position" to leverage the growing industry coupled with its place as a Nasdaq-listed company.
納努拉 回應了這一觀點，並補充說，他認爲露西處於 “獨特的地位”，可以利用不斷增長的行業及其作爲納斯達克上市公司的地位。
Wondering about the latest in the cannabis business world? Get ahead by attending Benzinga's Cannabis Capital Conference!
想知道大麻商業界的最新消息嗎？參加 Benzinga 的大麻資本會議，取得成功！
Taking place in Chicago on Sept 27-28, the 17th edition of CCC is the place to get DEALS DONE. Join us by getting your tickets today before prices increase.
第17屆CCC將於9月27日至28日在芝加哥舉行，是完成交易的地方。在價格上漲之前立即獲取門票，加入我們。
Photo: Benzinga edit with photo by Pexels.
照片：Benzinga 使用 Pexels 的照片進行編輯。
譯文內容由第三人軟體翻譯。